Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Metagenomic Analysis and Postoperative Pain in Infected Root Canals Using Different Irrigation Protocols

NCT07546773 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-04-30
Last updated
2026-05-04

Condition(s) studied

Dental Pulp NecrosisPulpitis

Investigational drug(s) / intervention(s)

Ultrasonic Irrigation ActivationLaser-Activated IrrigationMechanical Irrigation ActivationNegative Pressure Irrigation

Ultrasonic Irrigation Activation: Sodium hypochlorite irrigation activated with ultrasonic device

Laser-Activated Irrigation: Laser-activated sodium hypochlorite with methylene blue photosensitizer

Mechanical Irrigation Activation: Mechanical activation device creating swirling motion

Negative Pressure Irrigation: Continuous irrigation with negative pressure suction

Study summary

Achieving effective root canal disinfection while minimizing postoperative pain is a critical goal in endodontic therapy. Advanced irrigation protocols, such as ultrasonic activation, laser activation, negative pressure irrigation (PulpSucker device), and mechanical activation (Easy Clean device), have shown promise in enhancing bacterial reduction within the root canal system. However, their impact on postoperative pain has not been fully explored.

This randomized controlled clinical trial aims to compare bacterial reduction and postoperative pain levels in infected root canals using four different irrigation protocols. The study will use metagenomic analysis to evaluate changes in bacterial community composition and the Visual Analogue Scale (VAS) to assess patient-reported pain levels at multiple time points postoperatively.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Adult patients aged 18-60 years * Requiring root canal treatment for teeth with necrotic pulp * Presence of periapical radiolucency confirmed radiographically * Good general health with no systemic diseases affecting healing outcomes * Willing to provide informed written consent * Available for follow-up appointments Exclusion Criteria: * Patients with open apices * Severe periodontal disease * Currently taking antibiotics * Allergy to study materials (lidocaine, sodium hypochlorite, methylene blue, latex) * Pregnant or breastfeeding women * Compromised immunity or systemic conditions (e.g., uncontrolled diabetes, HIV, immunosuppressive therapy) * Previous root canal treatment on the study tooth * Tooth not restorable * Presence of vertical root fracture

Primary outcome measure(s)

  • Outcome 1: Bacterial Reduction — Pre-irrigation (baseline "Day-1") to post-irrigation "Day-1" after irrigation)
    Change in bacterial load (CFU/mL or relative abundance via metagenomic sequencing). Bacterial samples collected before and after irrigation protocol using sterile paper points, analyzed via next-generation sequencing (NGS) to assess bacterial reduction and changes in microbial community composition
  • Outcome 2: Postoperative Pain Level — 6 hours, 24 hours, 48 hours, and 7 days post-treatment
    Patient-reported pain intensity using VAS where 0=no pain, 1-3=mild pain, 4-6=moderate pain, 7-9=severe tolerable pain, 10=severe intolerable pain. Measure: Visual Analogue Scale (VAS) score (0-10 scale)

Trial sites (1)

FacilityCityRegionStatus
Endodontic Clinic, Faculty of Dentistry, Suez Canal University Ismailia Ismailia Governorate
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07546773 on ClinicalTrials.gov ↗ ← All trials in Egypt